Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 3, 2014, Pages 621-631

  Akdis, Mübeccel ^a   Akdis, Cezmi A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

allergen immunotherapy; B cells; basophils; eosinophils; IgE; IgG; IL 10; immune tolerance; immunotherapy; mast cells; Regulatory T cells; T cells; T helper cells; TGF

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; COMPLEMENT COMPONENT C1Q; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HISTAMINE RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHOLIPASE A2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ALLERGIC DISEASE; ANTIBODY RESPONSE; B LYMPHOCYTE; BASOPHIL; BASOPHIL DEGRANULATION; CELL LINE; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DESENSITIZATION; DRUG MECHANISM; EFFECTOR CELL; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SUBLINGUAL IMMUNOTHERAPY; TH1 CELL; TH17 CELL; TH2 CELL;

ALLERGEN IMMUNOTHERAPY; B CELLS; BASOPHILS; EOSINOPHILS; IGE; IGG; IL-10; IMMUNE TOLERANCE; IMMUNOTHERAPY; MAST CELLS; REGULATORY T CELLS; T CELLS; T HELPER CELLS; TGF-Β;

ALLERGENS; ANIMALS; B-LYMPHOCYTES, REGULATORY; BASOPHILS; DESENSITIZATION, IMMUNOLOGIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; MAST CELLS; RECEPTORS, HISTAMINE H2; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84895196467     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.12.1088     Document Type: Review

References (107)

1. A.W. Burks, M.A. Calderon, T. Casale, L. Cox, P. Demoly, and M. Jutel et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report J Allergy Clin Immunol 131 2013 1288 1296.e3
2. M.A. Calderon, T. Casale, L. Cox, C.A. Akdis, A.W. Burks, and H.S. Nelson et al. Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report Allergy 68 2013 825 828
3. J.M. Bae, Y.Y. Choi, C.O. Park, K.Y. Chung, and K.H. Lee Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials J Allergy Clin Immunol 132 2013 110 117
4. S.Y. Lin, N. Erekosima, J.M. Kim, M. Ramanathan, C. Suarez-Cuervo, and Y. Chelladurai et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review JAMA 309 2013 1278 1288
5. M.C. Berin, and L. Mayer Can we produce true tolerance in patients with food allergy? J Allergy Clin Immunol 131 2013 14 22
6. C.A. Akdis Therapies for allergic inflammation: refining strategies to induce tolerance Nat Med 18 2012 736 749
7. C.A. Akdis Allergy and hypersensitivity: mechanisms of allergic disease Curr Opin Immunol 18 2006 718 726
8. M. Akdis, and A.C. Akdis Immune tolerance N.F. Adkinson Jr. B.S. Bochner, A.W. Burks, W.W. Busse, S.T. Holgate, R.F. Lemanske Jr. Middleton's allergy: principles and practice 8th ed. 2013 Elsevier Amsterdam
9. S.R. Durham, W. Emminger, A. Kapp, G. Colombo, J.G. de Monchy, and S. Rak et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet J Allergy Clin Immunol 125 2010 131 138 e1-7
10. M. Akdis, and C.A. Akdis Therapeutic manipulation of immune tolerance in allergic disease Nat Rev Drug Discov 8 2009 645 660
11. F. Meiler, J. Zumkehr, S. Klunker, B. Ruckert, C.A. Akdis, and M. Akdis In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure J Exp Med 205 2008 2887 2898
12. T.A. Platts-Mills, and J.A. Woodfolk Allergens and their role in the allergic immune response Immunol Rev 242 2011 51 68
13. M. Jutel, W. Van de Veen, I. Agache, K.A. Azkur, M. Akdis, and C.A. Akdis Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development Allergol Int 62 2013 425 433
14. M. Akdis, O. Palomares, W. van de Veen, M. van Splunter, and C.A. Akdis TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection J Allergy Clin Immunol 129 2012 1438 1451
15. M. Akdis, S. Burgler, R. Crameri, T. Eiwegger, H. Fujita, and E. Gomez et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases J Allergy Clin Immunol 127 2011 701 721 e1-70
16. C.B. Smarr, P.J. Bryce, and S.D. Miller Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases Crit Rev Immunol 33 2013 389 414
17. J. Lotvall, C.A. Akdis, L.B. Bacharier, L. Bjermer, T.B. Casale, and A. Custovic et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome J Allergy Clin Immunol 127 2011 355 360
18. C.A. Akdis, C. Bachert, C. Cingi, M.S. Dykewicz, P.W. Hellings, and R.M. Naclerio et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology J Allergy Clin Immunol 131 2013 1479 1490
19. A. Romano, M.J. Torres, M. Castells, M.L. Sanz, and M. Blanca Diagnosis and management of drug hypersensitivity reactions J Allergy Clin Immunol 127 Suppl 2011 S67 S73
20. B. Eberlein-Konig, S. Ullmann, P. Thomas, and B. Przybilla Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization Clin Exp Allergy 25 1995 704 712
21. H. Plewako, K. Wosinska, M. Arvidsson, J. Bjorkander, P.S. Skov, and L. Hakansson et al. Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy Int Arch Allergy Immunol 141 2006 346 353
22. N. Novak, N. Mete, C. Bussmann, L. Maintz, T. Bieber, and M. Akdis et al. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 J Allergy Clin Immunol 130 2012 1153 1158
23. L.K. James, M.H. Shamji, S.M. Walker, D.R. Wilson, P.A. Wachholz, and J.N. Francis et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies J Allergy Clin Immunol 127 2011 509 516 e1-5
24. C.A. Akdis, T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser Role of interleukin 10 in specific immunotherapy J Clin Invest 102 1998 98 106
25. S.M. Walker, S.R. Durham, S.J. Till, G. Roberts, C.J. Corrigan, and S.C. Leech et al. Immunotherapy for allergic rhinitis Clin Exp Allergy 41 2011 1177 1200
26. F. Meiler, S. Klunker, M. Zimmermann, C.A. Akdis, and M. Akdis Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors Allergy 63 2008 1455 1463
27. H.B. Oral, S.V. Kotenko, M. Yilmaz, O. Mani, J. Zumkehr, and K. Blaser et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 Eur J Immunol 36 2006 380 388
28. W. van de Veen, B. Stanic, G. Yaman, M. Wawrzyniak, S. Sollner, and D.G. Akdis et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses J Allergy Clin Immunol 131 2013 1204 1212
29. M. Jutel, W.J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U.R. Müller Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen stimulated T cell cultures J Immunol 154 1995 4178 4194
30. M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, and K. Blaser et al. IL-10 and TGF-b cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 2003 1205 1214
31. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, and R. Crameri et al. Immune responses in healthy and allergic Individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med 199 2004 1567 1575
32. J.N. Francis, S.J. Till, and S.R. Durham Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy J Allergy Clin Immunol 111 2003 1255 1261
33. C. Mauri, and A. Bosma Immune regulatory function of B cells Annu Rev Immunol 30 2012 221 241
34. R. Van Ree, W.A. Van Leeuwen, P.H. Dieges, R.G. Van Wijk, N. De Jong, and P.Z. Brewczyski et al. Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy Clin Exp Allergy 27 1997 68 74
35. J. Bousquet, P. Braquemond, J. Feinberg, B. Guerin, H.J. Maasch, and F.B. Michel Specific IgE response with a standardized allergen or allergoid in grass pollen allergy Ann Allergy 56 1986 456 459
36. G.J. Gleich, E.M. Zimmermann, L.L. Henderson, and J.W. Yunginger Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study J Allergy Clin Immunol 70 1982 261 271
37. L.M. Lichtenstein, K. Ishizaka, P. Norman, A. Sobotka, and B. Hill IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy J Clin Invest 52 1973 472 482
38. J. Bousquet, H. Maasch, B. Martinot, A. Hejjaoui, R. Wahl, and F.B. Michel Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy J Allergy Clin Immunol 82 1988 439 446
39. S. Flicker, and R. Valenta Renaissance of the blocking antibody concept in type I allergy Int Arch Allergy Immunol 132 2003 13 24
40. P.A. Wachholz, and S.R. Durham Mechanisms of immunotherapy: IgG revisited Curr Opin Allergy Clin Immunol 4 2004 313 318
41. D.B. Golden, D.A. Meyers, A. Kagey-Sobotka, M.D. Valentine, and L.M. Lichtenstein Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy J Allergy Clin Immunol 69 1982 489 493
42. U.R. Müller, A. Helbling, and M. Bischof Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom Allergy 44 1989 412 418
43. K.T. Nouri-Aria, P.A. Wachholz, J.N. Francis, M.R. Jacobson, S.M. Walker, and L.K. Wilcock et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity J Immunol 172 2004 3252 3259
44. M. Jutel, L. Jaeger, R. Suck, H. Meyer, H. Fiebig, and O. Cromwell Allergen-specific immunotherapy with recombinant grass pollen allergens J Allergy Clin Immunol 116 2005 608 613
45. H.P. Van Bever, and W.J. Stevens Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) Clin Exp Allergy 19 1989 399 404
46. S. Rak, O. Rowhagen, and P. Venge The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients J Allergy Clin Immunol 82 1988 470 480
47. V.A. Varney, J. Edwards, K. Tabbah, H. Brewster, G. Mavroleon, and A.J. Frew Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial Clin Exp Allergy 27 1997 860 867
48. L. Hakansson, C. Heinrich, S. Rak, and P. Venge Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy J Allergy Clin Immunol 99 1997 551 562
49. P.S. Creticos, N.F. Adkinson Jr., A. Kagey-Sobotka, D. Proud, H.L. Meier, and R.M. Naclerio et al. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy J Clin Invest 76 1985 2247 2253
50. W.Y. Chen, J. Yu, and J.Y. Wang Decreased production of endothelin-1 in asthmatic children after immunotherapy J Asthma 32 1995 29 35
51. C. Walker, J.-C. Virchow, P.L.B. Bruijnzeel, and K. Blaser T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma J Immunol 146 1991 1829 1835
52. R.P. Schleimer, C.P. Derse, B. Friedman, S. Gillis, M. Plaut, and L.M. Lichtenstein et al. Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids J Immunol 143 1989 1310 1327
53. S. Treter, and M. Luqman Antigen-specific T cell tolerance down-regulates mast cell responses in vivo Cell Immunol 206 2000 116 124
54. Y.K. Shim, B.S. Kim, S.H. Cho, K.U. Min, and S.J. Hong Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability Clin Exp Allergy 33 2003 52 57
55. J.S. Marshall, I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells J Clin Invest 97 1996 1122 1128
56. L. Schandane, C. Alonso-Vega, F. Willems, C. Gerard, A. Delvaux, and T. Velu et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10 J Immunol 152 1994 4368 4374
57. Y. Ohkawara, K.G. Lim, M. Glibetic, K. Nakano, J. Dolovich, and K. Croitoru et al. CD40 expression by human peripheral blood eosinophils J Clin Invest 97 1996 1761 1766
58. R.K. Gershon A disquisition on suppressor T cells Transplant Rev 26 1975 170 185
59. S.Z. Josefowicz, R.E. Niec, H.Y. Kim, P. Treuting, T. Chinen, and Y. Zheng et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation Nature 482 2012 395 399
60. S. Strober, L. Cheng, D. Zeng, R. Palathumpat, S. Dejbakhsh-Jones, and P. Huie et al. Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity Immunol Rev 149 1996 217 230
61. C. Mauri, D. Gray, N. Mushtaq, and M. Londei Prevention of arthritis by interleukin 10-producing B cells J Exp Med 197 2003 489 501
62. G. Deniz, W. van de Veen, and M. Akdis Natural killer cells in patients with allergic diseases J Allergy Clin Immunol 132 2013 527 535
63. C. Sackesen, W. van de Veen, M. Akdis, O. Soyer, J. Zumkehr, and B. Ruckert et al. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides Allergy 68 2013 593 603
64. K.J. Maloy, and F. Powrie Regulatory T cells in the control of immune pathology Nat Immunol 2 2001 816 822
65. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat Rev Immunol 3 2003 253 257
66. A. O'Garra, and P. Vieira Regulatory T cells and mechanisms of immune system control Nat Med 10 2004 801 805
67. M.S. Jordan, A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, and M.A. Lerman et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide Nat Immunol 2 2001 301 306
68. S. Sakaguchi Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
69. W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, and N. Marinos et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
70. C.M. Hawrylowicz, and A. O'Garra Potential role of interleukin-10- secreting regulatory T cells in allergy and asthma Nat Rev Immunol 5 2005 271 283
71. S. Sakaguchi The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery J Clin Invest 112 2003 1310 1312
72. S. Sakaguchi, D.A. Vignali, A.Y. Rudensky, R.E. Niec, and H. Waldmann The plasticity and stability of regulatory T cells Nat Rev Immunol 13 2013 461 467
73. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329 341
74. S. Klunker, M.M.W. Chong, P.Y. Mantel, O. Palomares, C. Bassin, and M. Ziegler et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells J Exp Med 206 2009 2701 2715
75. T.A. Chatila, F. Blaeser, N. Ho, H.M. Lederman, C. Voulgaropoulos, and C. Helms et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome J Clin Invest 106 2000 R75 R81
76. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, and L. Whitesell et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
77. K. Orihara, M. Narita, T. Tobe, A. Akasawa, Y. Ohya, and K. Matsumoto et al. Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects J Allergy Clin Immunol 120 2007 960 962
78. J.L. Coombes, K.R. Siddiqui, C.V. Arancibia-Carcamo, J. Hall, C.M. Sun, and Y. Belkaid et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism J Exp Med 204 2007 1757 1764
79. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A.H. Enk Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells J Exp Med 192 2000 1213 1222
80. T. Ito, M. Yang, Y.H. Wang, R. Lande, J. Gregorio, and O.A. Perng et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand J Exp Med 204 2007 105 115
81. W. Chen, X. Liang, A.J. Peterson, D.H. Munn, and B.R. Blazar The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation J Immunol 181 2008 5396 5404
82. U.C. Kucuksezer, O. Palomares, B. Ruckert, T. Jartti, T. Puhakka, and A. Nandy et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood J Allergy Clin Immunol 131 2013 875 885.e9
83. O. Palomares, B. Rückert, T. Jartti, U.C. Kücüksezer, T. Puhakka, and E. Gomez et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance J Allergy Clin Immunol 129 2012 510 520
84. P.Y. Mantel, H. Kuipers, O. Boyman, C. Rhyner, N. Ouaked, and B. Ruckert et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells PLoS Biol 5 2007 e329
85. L. Zhang, and Y. Zhao The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road J Cell Physiol 211 2007 590 597
86. P.R. Mangan, L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, and C.O. Elson et al. Transforming growth factor-beta induces development of the T(H)17 lineage Nature 441 2006 231 234
87. A. Zimmer, J. Bouley, M. Le Mignon, E. Pliquet, S. Horiot, and M. Turfkruyer et al. A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy J Allergy Clin Immunol 129 2012 1020 1030
88. M.O. Li, Y.Y. Wan, S. Sanjabi, A.K. Robertson, and R.A. Flavell Transforming growth factor-beta regulation of immune responses Annu Rev Immunol 24 2006 99 146
89. M.H. Branton, and J.B. Kopp TGF-beta and fibrosis Microbes Infect 1 1999 1349 1365
90. A. Taylor, M. Akdis, A. Joss, T. Akkoc, R. Wenig, and M. Colonna et al. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1 J Allergy Clin Immunol 120 2007 76 83
91. A. Joss, M. Akdis, A. Faith, K. Blaser, and C.A. Akdis IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway Eur J Immunol 30 2000 1683 1690
92. A. Taylor, J. Verhagen, T. Akkoc, R. Wenig, E. Flory, and K. Blaser et al. IL-10 suppresses CD2-mediated T cell activation via SHP-1 Mol Immunol 46 2009 622 629
93. Z. Urry, E. Xystrakis, and C.M. Hawrylowicz Interleukin-10-secreting regulatory T cells in allergy and asthma Curr Allergy Asthma Rep 6 2006 363 371
94. L. O'Mahony, M. Akdis, and C.A. Akdis Regulation of the immune response and inflammation by histamine and histamine receptors J Allergy Clin Immunol 128 2011 1153 1162
95. J. Del Valle, and I. Gantz Novel insights into histamine H2 receptor biology Am J Physiol 273 1997 G987 G996
96. M. Jutel, T. Watanabe, S. Klunker, M. Akdis, O.A.R. Thomet, and J. Malolepszy et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors Nature 413 2001 420 425
97. A. Mazzoni, H.A. Young, J.H. Spitzer, A. Visintin, and D.M. Segal Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization J Clin Invest 108 2001 1865 1873
98. N. Osna, K. Elliott, and M.M. Khan Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes Int Immunopharmacol 1 2001 85 96
99. S. Kunzmann, P.-Y. Mantel, J.G. Wohlfahrt, M. Akdis, K. Blaser, and C.B. Schmidt-Weber Histamine enhances TGF-beta1-mediated suppression of Th2 responses FASEB J 17 2003 1089 1095
100. D.R. Wilson, M.T. Lima, and S.R. Durham Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis Allergy 60 2005 4 12
101. S. Radulovic, D. Wilson, M. Calderon, and S. Durham Systematic reviews of sublingual immunotherapy (SLIT) Allergy 66 2011 740 752
102. N.N. Bahceciler, C. Arikan, A. Taylor, M. Akdis, K. Blaser, and I.B. Barlan et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites Int Arch Allergy Immunol 136 2005 287 294
103. G. Ciprandi, D. Fenoglio, I. Cirillo, A. Vizzaccaro, A. Ferrera, and M.A. Tosca et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report Ann Allergy Asthma Immunol 95 2005 38 44
104. C. Rolinck-Werninghaus, M. Kopp, C. Liebke, J. Lange, U. Wahn, and B. Niggemann Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen Int Arch Allergy Immunol 136 2005 134 141
105. J. Savolainen, L. Jacobsen, and E. Valovirta Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC Allergy 61 2006 1184 1190
106. F. Marcucci, L.G. Sensi, E. Migali, and G. Coniglio Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma Allergy 56 2001 231 236
107. F. Marcucci, L. Sensi, F. Frati, R. Bernardini, E. Novembre, and A. Barbato et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites Allergy 58 2003 657 662